Health
New study to examine the effects of MS disease-modifying therapy on cognitive fatigue – News-Medical.Net
Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab…
Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS).
John DeLuca, PhD, senior vice president of Research and Training, is principal investigator for the study titled, “A Biomarker for Cognitive Fatigue in MS using Functional Imaging”. The study team includes Glenn Wylie, DPhil, director…
-
General23 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
General12 hours agoThailand punches above its weight in film creativity and cross-border appeal. Here’s why
-
General23 hours agoOfficer-induced jeopardy • Inside Story
-
Noosa News10 hours agoMitch Power Quick Shear event gets men talking about mental health